Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (9421)	3/29/1999 7:53:00 PM
From: aknahow	Respond to of 17367

Perhaps Bluegreen is suffering from trauma. He or anyone that reads this magazine should let us know what the following articles say. Only the Table of Contents is online. Applicable articles are listed below. Volume 27 / Number 2 February 1999 Table of Contents EDITORIALS Advertisements for ourselves—Let's be cautious interpreting outcome studies of critical care services Jesse B. Hall Mechanisms and management of myocardial dysfunction in septic shock Charles M. Carpati, Mark E. Astiz, Eric C. Rackow Toward new definitions of acute respiratory distress syndrome Edward Abraham TNF in Trauma—Whither Our Focus? H. David Reines Tumor necrosis factor receptor expression on inflammatory cells in sepsis Steven M. Opal Cellular drug interaction in the fight against multidrug resistant cancer Timothy E. Albertson, Frederick Meyers PEEP: Blood gas cosmetics or a therapy for ARDS? Antonio Presenti, Roberto Fumagalli Expired nitric oxide and shock in higher order species Daniel L. Traber FEATURE ARTICLES CLINICAL INVESTIGATIONS The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome Jérôme Pugin, George Verghese, Marie-Claude Widmer, Michael A. Matthay The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries Matthias Majetschak, Regina Flach, Ernst Kreuzfelder, Veronika Jennissen, Tatjana Heukamp, Friedrich Neudeck, Klaus Peter Schmit-Neuerburg, Udo Obertacke, F. Ulrich Schade Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome Wolfgang Hübl, Georg Wolfbauer, Johannes Streicher, Sylvia Andert, Günther Stanek, Sylvia Fitzal, Peter Michael Bayer LABORATORY INVESTIGATIONS POINT OF VIEW Sepsis research: We must change course Stanley A. Nasraway, Jr ANOTHER POINT OF VIEW Futility of randomized, controlled ARDS trials—A new approach is needed Bradley P. Fuhrman, Edward Abraham, R. Phillip Dellinger Research in sepsis and acute respiratory distress syndrome: Are we changing course? Gordon R. Bernard wwilkins.com